Gregory L. Hundemer

Internal Medicine

81 Highland Ave
Salem, MA 01970

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 157 publications

Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: July 22, 2026

Severity of Chronic Kidney Disease and Outcomes After Admission to the Intensive Care Unit.

Severity of Chronic Kidney Disease and Outcomes After Admission to the Intensive Care Unit.

Journal: JAMA network open

Published: June 25, 2026

Aldosterone in Hypertension: From Secondary Cause to Central Driver.

Aldosterone in Hypertension: From Secondary Cause to Central Driver.

Journal: The Canadian journal of cardiology

Published: June 16, 2026

Agreement Between Molecular Imaging and Adrenal Vein Sampling for Localization in Primary Aldosteronism: A Systematic Review.

Agreement Between Molecular Imaging and Adrenal Vein Sampling for Localization in Primary Aldosteronism: A Systematic Review.

Journal: Journal of the American Heart Association

Published: May 30, 2026

Incident Hypertension in Young Adults With a Mild Estimated Glomerular Filtration Rate Reduction.

Incident Hypertension in Young Adults With a Mild Estimated Glomerular Filtration Rate Reduction.

Journal: Journal of the American Heart Association

Published: April 29, 2026

Authors' Reply: Aldosterone-to-Renin Ratio and eGFR Decline: Sensitivity to the Renin Assay Floor.

Authors' Reply: Aldosterone-to-Renin Ratio and eGFR Decline: Sensitivity to the Renin Assay Floor.

Journal: Journal of the American Society of Nephrology : JASN

Published: April 01, 2026

Response by Hundemer and Vaidya to Letter Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".

Response by Hundemer and Vaidya to Letter Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".

Journal: Circulation

Published: March 30, 2026

Hydralazine Use and Risk of Vasculitis.

Hydralazine Use and Risk of Vasculitis.

Journal: JAMA network open

Published: March 16, 2026

Treatment of Primary Aldosteronism.

Treatment of Primary Aldosteronism.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: March 11, 2026

Big Data Approach to Assessment of an Aldosterone-Renin Ratio for Detection of Potential Surgical Cases of Primary Aldosteronism.

Big Data Approach to Assessment of an Aldosterone-Renin Ratio for Detection of Potential Surgical Cases of Primary Aldosteronism.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: March 04, 2026

Big Data Approach to Assessment of an Aldosterone-Renin Ratio for Detection of Potential Surgical Cases of Primary Aldosteronism.

Big Data Approach to Assessment of an Aldosterone-Renin Ratio for Detection of Potential Surgical Cases of Primary Aldosteronism.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: March 04, 2026

Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study.

Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study.

Journal: The Canadian journal of cardiology

Published: February 12, 2026

Showing 1-12 of 157

Last Updated: 09/26/2026